openPR Logo
Press release

Favipiravir Market Provides in-depth analysis of the Industry, with Current Trends and Future Estimations to Elucidate the Investment Pockets | (2020-2027)

04-22-2020 03:54 PM CET | Health & Medicine

Press release from: Market Expertz

Favipiravir Market

Favipiravir Market

Favipiravir (T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Favipiravir was discovered through screening chemical library for anti-viral activity against the influenza virus by Toyama Chemical Co., Ltd. Favipiravir undergoes an intracellular phosphoribosylation to be an active form, favipiravir-RTP (favipiravir ribofuranosyl-5'-triphosphate), which is recognized as a substrate by RdRp, and inhibits the RNA polymerase activity.

Since the catalytic domain of RdRp is conserved among various types of RNA viruses, this mechanism of action underpins a broader spectrum of anti-viral activities of favipiravir. Favipiravir is effective against a wide range of types and subtypes of influenza viruses, including strains resistant to existing anti-influenza drugs. Of note is that favipiravir shows anti-viral activities against other RNA viruses such as arenaviruses, bunyaviruses and filoviruses, all of which are known to cause fatal hemorrhagic fever. These unique anti-viral profiles will make favipiravir a potentially promising drug for specifically untreatable RNA viral infections.

Fujifilm Toyama Chemical has started a Phase III clinical trial of its antiviral influenza drug Avigan (favipiravir) for the treatment of Covid-19 patients in Japan. Avigan specifically blocks RNA polymerase associated with influenza viral replication. The mechanism is expected to have an antiviral effect on SARS-CoV-2, the novel coronavirus that causes Covid-19.

In Japan, the new Phase III trial will assess Avigan's safety and efficacy as a potential Covid-19 treatment. According to the study data, the drug was able to shorten the recovery time from 11 days to four days for mild and moderate cases.

Generics drugmaker Beximco (AIM: BXP) says its pharmaceutical division and fellow Bangladesh-based Beacon Pharmaceuticals have developed favipiravir, an antiviral drug that is being used by China to treat COVID-19 patients

In this report, the global Favipiravir market is valued at USD xx billion in 2020 and is expected to reach around USD xx billion by the end of 2027, growing at a CAGR of around xx% between 2019 and 2027.

Get Access to sample pages@

Scope of the report:

The report evaluates updated financial information sourced through both primary and secondary sources of data collection to offer accurate market insights. It also assesses critical market trends that are expected to have a favorable impact on the market in the coming years, including a detailed examination of the market segments on both regional and global scales. The report also offers a holistic overview of the market share along with strategic recommendations, emphasizing the nascent market segments.

In market segmentation by manufacturers, the report covers the following companies-

Fujifilm Toyama Chemical


Hunan Huateng Pharmaceutical Co., Ltd

Lasa Supergenerics Limited

Shouyuan chemical

Zhejiang HISUN Pharmaceuticals Co., Ltd

Toyama Chemica

The report assesses the current competitive scenario, highlighting the activities undertaken by key participants in the market. Commercial activities like product launches, joint ventures, mergers and acquisitions, collaborations, and other deals have also been scrutinized in the report. Furthermore, the report segments the market based on product type, applications, end-users, business verticals, and geographical regions. It also offers an in-depth analysis of the major drivers, restraints, opportunities, challenges, and prospects affecting the overall market along with the market estimates and forecasts of the revenue.

For Discount on this Favipiravir Market Report: Visit@

In market segmentation by types of Favipiravir, the report covers-

20 Tablets/Box

40 Tablets/Box

In market segmentation by applications of the Favipiravir, the report covers the following uses-

COVID-19 Treatment



Drug Store


The Global Favipiravir Market report also offers the regional segmentation, emphasizing on the expected growth of each geographical region, taking into account the growth rate, micro- and macro-economic indicators, upstream and downstream industries, regulatory framework, growth trends, shift in consumer preferences, and the demand and supply dynamics.

Be the first to tap the potential that the regions in the Favipiravir market hold. Identify the Threats and Opportunities to derive the most useful insights from our research publication to stay ahead in the competition. Buy this research report@

Which player is poised to lead the market in 2020?
2020 is expected to be a big year for the Favipiravir Market in terms of growth. As more companies in the market move some or all of their applications, emerging players are poised to benefit.

What are the recent trends in the Favipiravir market?
According to Market Expertz, key business segments sales will cross the USD XX mark in 2020, signaling changing consumer preferences. Apart from classified segments that are popular in the industry i.e. by Type, by End-Users/Application, the latest 2020 version is further broken down to highlight emerging trends in the global industry.

What are the market positions of the Favipiravir companies?
With the latest earning release, Industry Players have disclosed their plans to expand their model for bringing new offerings to the market faster and with more precision. Manufacturers and consumers are getting a glimpse of this process with new products; hence, the research gives an extensive demand analysis to better understand consumer behavior and changing preferences.

With increased investments, market giants are introducing new products in the market. The report studies how effective the new product lines will be and just how much growth it would witness.

Research objectives

To study and analyze the Favipiravir Market size by key regions/countries, product type and application, historical data from 2016 to 2018, and forecast to 2026.
To identify the key market players.
To understand the structure of Favipiravir Market by identifying its various sub-segments.
To define, describe, and analyze the value, market share, market competition landscape, and the industry chain for the next few years.
To analyze the Favipiravir Market with respect to individual growth trends, future prospects, and the contribution of the leading players to the global market.
To share detailed information about key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the prospective growth in the size of Favipiravir Market with respect to key regions, type, and applications.
To analyze competitive developments such as expansions, agreements, new product launches, and mergers & acquisitions in the market.

Read Detailed Table of Contents in the Complete Research Study@

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Contact Us:
John Watson
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-800-819-3052
Visit our News Site:

About Us:
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Favipiravir Market Provides in-depth analysis of the Industry, with Current Trends and Future Estimations to Elucidate the Investment Pockets | (2020-2027) here

News-ID: 2020794 • Views: 718

More Releases from Market Expertz

Cloud Security Market to Reflect Significant Growth during 2020-2027 | IBM Corporation, Cisco Systems, Fortinet Inc, BMC Software, etc.
Cloud Security Market to Reflect Significant Growth during 2020-2027 | IBM Corpo …
Industry Overview of Cloud Security Market Report 2020 The global cloud security market is expected to reach USD 32.39 Billion by 2027. Escalating BYOD (Bring Your Own Device) trend in various organizations is driving the growth of the cloud security market. BYOD helps in reducing hardware procuring and maintenance, which is beneficial in reducing organizational cost. Nevertheless, the key challenge with BYOD is providing security to a wide variety of devices,
Farm Management Software and Services Market: Future Demand, Market Analysis & Outlook for 2027 | Deere & Company, Trimble, Ag Junction, Raven Industries, etc.
Farm Management Software and Services Market: Future Demand, Market Analysis & O …
Farm Management Software and Services Market with key Business Factors and Insights The global Farm Management Software and Services Market is forecasted to reach USD 3.24 Billion by 2027, according to a new report by Reports and Data. The rising trend of remote sensing technologies for consistent monitoring is propelling the market demand. The constant vigil provides farmers with real-time weather information and also enables them to reduce the impact of
Global Advanced Sterilization Products Market Insights and In-Depth Analysis 2020-2027 | Sotera Health, Advanced Sterilization Products, Cardinal Health, Noxilizer Inc, etc.
Global Advanced Sterilization Products Market Insights and In-Depth Analysis 202 …
Advanced Sterilization Products Market with key Business Factors and Insights The global Advanced Sterilization Products market is forecast to reach USD 13.06 billion by 2027, according to a new report by Reports and Data. The global market for sterilization is increasing considerably from the increasing implementation of dominant norms regarding preserving food quality, the developing demand for food supply, and the rising preference for crops. The carriage of strict medical safety
Ingestible Smart Pills Market Booming Worldwide with leading Players BodyCap-Medical, Philips Respironics, Given Imaging Ltd, Olympus Corporation, etc.
Ingestible Smart Pills Market Booming Worldwide with leading Players BodyCap-Med …
Ingestible Smart Pills Market with key Business Factors and Insights The Ingestible Smart Pills Market Report gives the most comprehensive and exhaustive coverage of the industry with business strategies as well as qualitative and quantitative analysis of the global market. It offers a detailed analysis of critical aspects of the Ingestible Smart Pills market (2019-2026). Analysts who have curated this report have provided in-depth information on drivers, restraints, challenges, trends, and opportunities to offer an extensive

All 5 Releases

More Releases for Favipiravir

Favipiravir Market to reach USD 247.2 Million - Risk-adjusted numbers with COVID …
The most recent study offered by Acumen Research and Consulting focuses Favipiravir Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Favipiravir Market trends in order to assess its current and future potential. Our Favipiravir Market analysis also provides market participants and new entrants with a comprehensive view of the
Favipiravir Market Size, Share, Growth, Market Trends, Outlook with Company Anal …
New Jersey, United States,- Favipiravir Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2022 to 2030. The Global Favipiravir Market research includes an in-depth analysis of key geographical trends, market dynamics, and global size estimates for the market industry. Product description, product classification, industry structure, and numerous participants in
Global Favipiravir Market Trends, Market Share, Industry Size, Growth, Opportuni …
The global favipiravirmarket is anticipated to grow at a significant CAGR of 4.1% during the forecast period (2022-2028). Favipiravir is a pyrazine carboxamide derivative that acts as an antiviral, which interrupts the viral replication process, preventing the virus from replicating inside the host. The favipiravir market is being driven by the rising prevalence of influenza and Ebola, among other diseases. Furthermore, the usage of this drug in the treatment of
Favipiravir Market Top Company, Geographical Region, and Industry Segments till …
LOS ANGELES, United States: The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Favipiravir  market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Favipiravir market. The authors of the report have segmented the global Favipiravir market as per product, application, and
Favipiravir Market Global Growth Opportunities and Market Scenario and Forecast …
The global Favipiravir Market" evaluation and insights 2021-2025 is a complete evaluation primarily based totally on in-intensity studies at the improvement environment, marketplace dynamics, opportunities, growth, insights, and rising technology of Favipiravir market. The examiner covers historic information from 2016 to 2021 in addition to predictions 2025, making it a precious useful resource for enterprise executives, rising technology, rising trends, proportion estimation, and nearby overview. By comparing the marketplace's segmentation,
The Global Favipiravir Market, Growth Analysis, Latest Trends and Forecast till …
Fabipravir, an antiviral medication, has been approved in various countries for the treatment of COVID-19, including Japan, Russia, and India. In September 2020, a fast meta-review (analysing four studies) found that the medicine improved clinical and radiological outcomes; nevertheless, no reduction in mortality or variations in oxygen-support requirements were seen, prompting the search for more robust investigations. In 2020, the global Favipiravir market size was US$ 299.4 million and it